Skip to main content

Thermo Fisher Files Registration Statement for Euro-denominated Senior Notes Offering

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today filed a prospectus for a euro-denominated offering of its senior notes due in 2025.

The company has not set the terms of the offering yet. Net proceeds from the offering will go toward repaying debt. HSBC, Deutsche Bank, and the Royal Bank of Scotland are listed as the underwriters for the offering.

Last week, Thermo Fisher priced its offering of $800 million of senior notes. The company said at the time that it also planned a euro-denominated offering of its senior notes before the end of the year, depending on market conditions.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.